Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

• Conditions: Idiopathic Pulmonary Fibrosis

• Registration Number: NCT04019080
• Lead Sponsor: Karolinska University Hospital

Brief Summary

The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Status Verified: 2019-07
• Study First Submitted: 2019-07-11
• Study First Submitted QC: 2019-07-11
• Last Update Submitted: 2019-07-11
• Study First Posted: 2019-07-15
• Last Update Posted: 2019-07-15
• Primary Completion: 2021-12
• Study Completion: 2021-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• All subjects included in the Swedish IPF-registry

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anti-fibrotic drugs among the patients recorded in the Swedish IPF-registry	2014-2020	The use of anti-fibrostic drugs

Trial Locations

Locations (1)

Karolinska University Hospital; 🇸🇪 Stockholm, Sweden